Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CNCKNYSE:MSDLNYSE:OBDENASDAQ:REVH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCNCKCoincheck Group$6.27+4.5%$6.10$4.22▼$14.42$813.22M0.1159,990 shs46,716 shsMSDLMorgan Stanley Direct Lending Fund$19.17+0.1%$19.39$17.59▼$23.68$1.69B0.34376,370 shs300,313 shsOBDEBlue Owl Capital Co. III$14.14$14.14$13.60▼$15.38$1.74BN/A250,580 shsN/AREVHRevolution Healthcare Acquisition$10.04$10.04$9.62▼$10.50$476.93M0.04183,205 shs371 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCNCKCoincheck Group0.00%+24.65%+10.97%+36.30%+626,999,900.00%MSDLMorgan Stanley Direct Lending Fund0.00%-0.31%-1.54%+4.70%-16.91%OBDEBlue Owl Capital Co. III0.00%0.00%0.00%0.00%-5.98%REVHRevolution Healthcare Acquisition0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCNCKCoincheck GroupN/AN/AN/AN/AN/AN/AN/AN/AMSDLMorgan Stanley Direct Lending Fund2.2211 of 5 stars2.13.01.70.00.61.71.9OBDEBlue Owl Capital Co. IIIN/AN/AN/AN/AN/AN/AN/AN/AREVHRevolution Healthcare AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCNCKCoincheck Group 3.00Buy$10.0059.49% UpsideMSDLMorgan Stanley Direct Lending Fund 2.20Hold$20.004.33% UpsideOBDEBlue Owl Capital Co. III 0.00N/AN/AN/AREVHRevolution Healthcare Acquisition 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest REVH, OBDE, MSDL, and CNCK Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2025MSDLMorgan Stanley Direct Lending FundRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$22.00 ➝ $21.004/28/2025MSDLMorgan Stanley Direct Lending FundWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$20.00 ➝ $19.004/24/2025MSDLMorgan Stanley Direct Lending FundJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$20.50 ➝ $19.504/17/2025MSDLMorgan Stanley Direct Lending FundUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$21.00 ➝ $20.504/8/2025MSDLMorgan Stanley Direct Lending FundKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetMarket Perform ➝ Market Perform$21.00 ➝ $20.00(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCNCKCoincheck Group$2.56B0.32N/AN/A$0.55 per share11.40MSDLMorgan Stanley Direct Lending Fund$416.08M4.05$2.44 per share7.85$20.82 per share0.92OBDEBlue Owl Capital Co. III$244.17M7.14$2.16 per share6.54$15.60 per share0.91REVHRevolution Healthcare AcquisitionN/AN/A$0.49 per share20.62($0.74) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCNCKCoincheck Group-$95.70MN/A0.00∞N/AN/A-359.24%-4.64%N/AMSDLMorgan Stanley Direct Lending Fund$215.56M$2.188.798.09N/A47.65%11.80%5.70%8/6/2025 (Estimated)OBDEBlue Owl Capital Co. III$271.96M$1.768.039.75N/A45.35%11.52%5.22%N/AREVHRevolution Healthcare Acquisition$21.35MN/A0.00∞N/AN/A-81.90%3.65%N/ALatest REVH, OBDE, MSDL, and CNCK EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025MSDLMorgan Stanley Direct Lending Fund$0.56$0.52-$0.04$0.34$102.86 million$101.50 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCNCKCoincheck GroupN/AN/AN/AN/AN/AMSDLMorgan Stanley Direct Lending Fund$2.0010.43%N/A91.74%N/AOBDEBlue Owl Capital Co. III$1.409.90%N/A79.55%N/AREVHRevolution Healthcare AcquisitionN/AN/AN/AN/AN/ALatest REVH, OBDE, MSDL, and CNCK DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/9/2025MSDLMorgan Stanley Direct Lending Fundquarterly$0.5010.8%6/30/20256/30/20257/25/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCNCKCoincheck GroupN/A1.071.01MSDLMorgan Stanley Direct Lending Fund1.111.361.36OBDEBlue Owl Capital Co. III1.281.761.76REVHRevolution Healthcare AcquisitionN/A2.682.68Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCNCKCoincheck Group33.22%MSDLMorgan Stanley Direct Lending FundN/AOBDEBlue Owl Capital Co. IIIN/AREVHRevolution Healthcare AcquisitionN/AInsider OwnershipCompanyInsider OwnershipCNCKCoincheck Group65.10%MSDLMorgan Stanley Direct Lending Fund0.21%OBDEBlue Owl Capital Co. III90.80%REVHRevolution Healthcare Acquisition1.23%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCNCKCoincheck GroupN/A129.70 million45.27 millionN/AMSDLMorgan Stanley Direct Lending FundN/A87.92 million87.74 millionOptionableOBDEBlue Owl Capital Co. IIIN/A123.36 millionN/AN/AREVHRevolution Healthcare Acquisition447.50 million46.92 millionNot OptionableREVH, OBDE, MSDL, and CNCK HeadlinesRecent News About These CompaniesThe $499 Revolution: Function Health’s Acquisition of Ezra Changes Preventive Care with AIMay 9, 2025 | alleywatch.comACivil War and RevolutionNovember 2, 2024 | bbc.co.ukNational Symposium for Healthcare ExecutivesOctober 3, 2024 | uab.eduUIn the healthcare and life sciences jungle – industry must adapt to surviveSeptember 18, 2024 | pharmaphorum.comPHealthcare must embrace the digital revolutionAugust 30, 2024 | pharmaphorum.comPHealth Care’s Value Revolution Focusing on Quality Over QuantityJuly 30, 2024 | providermagazine.comPThe AI Revolution In Healthcare: How Legacy Providers Can AdaptJuly 29, 2024 | forbes.comRevolution Bars Group Declines Nightcap Takeover ProposalMay 28, 2024 | marketwatch.comThe lowly Revolution are showing improvement, but they need an offensive upgrade to truly competeMay 13, 2024 | bostonglobe.comBRevolution Bars Considering All Options After Rival Nightcap Shows InterestMay 7, 2024 | marketwatch.comNavigating the AI Revolution: Leadership Trends in HealthcareApril 10, 2024 | beckershospitalreview.comBReviewing 10 Of Healthcare Boldest Moves In Recent HistoryFebruary 4, 2024 | forbes.comAI is on the cusp of a revolutionJanuary 30, 2024 | healthcarefinancenews.comHThe therapy revolutionJune 15, 2023 | dailymail.co.ukSyntax delivers index universes for Healthcare Innovations and Technology Revolution strategies on SmartTrust® UIT platformJune 1, 2023 | finance.yahoo.comHealthcare Revolution: Medical Tourism and the American DreamApril 26, 2023 | finance.yahoo.comExecutive behind ChatGPT pushes for a new revolution: PsychedelicsApril 25, 2023 | washingtonpost.comPhilips Healthcare's Revolution Rotational IVUS Imaging CatheterMarch 26, 2023 | news-medical.netNAli Health: A Revolution for China’s Healthcare Industry?March 16, 2023 | thediplomat.comTNHS launches healthcare revolution to ditch drugsMarch 1, 2023 | express.co.ukNew MarketBeat Followers Over TimeMedia Sentiment Over TimeREVH, OBDE, MSDL, and CNCK Company DescriptionsCoincheck Group NASDAQ:CNCK$6.27 +0.27 (+4.50%) As of 07/3/2025 01:00 PM EasternCoincheck Group NV. is a Dutch public limited liability company and a holding company of Coincheck, Inc. which operates one of the largest multi-cryptocurrency marketplaces and crypto asset exchanges in Japan and is regulated by the Financial Services Agency of Japan. The company was founded on February 18, 2022 and is headquartered in Amsterdam, Netherland.Morgan Stanley Direct Lending Fund NYSE:MSDL$19.17 +0.02 (+0.10%) As of 07/3/2025 03:30 PM EasternMorgan Stanley Direct Lending Fund is a business development company. It is a non-diversified, externally managed specialty finance company focused on lending to middle-market companies. Morgan Stanley Direct Lending Fund is based in NEW YORK.Blue Owl Capital Co. III NYSE:OBDE$14.14 0.00 (0.00%) As of 01/24/2025Blue Owl Capital Corporation is a specialty finance company focused on lending to U.S. middle-market companies. Blue Owl Capital Corporation is based in NEW YORK.Revolution Healthcare Acquisition NASDAQ:REVHRevolution Healthcare Acquisition Corp. does not have significant operations. The company intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination. It focuses on pursuing opportunities in health care, life sciences, and technology industries. The company was incorporated in 2021 and is based in Cambridge, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Correction Equals Opportunity in Domino’s Pizza Stock Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
